The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A concise guide on selecting core crypto assets for beginners who plan to buy and hold for the long term.
28,656 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Oil ETFs have soared 100% plus this year, underscoring a powerful rebound in crude. This report breaks down what’s dr...
A former hedge fund executive assistant goes public with a memoir detailing the grind behind elite money management. ...
Freshworks’ chief executive says agile, foundation-first transformation is driving AI wins for enterprises in 2026. T...
Broadcom faces a fast-changing AI compute cycle that could lift shares toward $630, backed by custom silicon demand a...
Three international dividend ETFs are delivering higher yields than SCHD in 2026, signaling a shift in income-focused...
Dell Technologies beat on revenue with a strong AI server push, while Super Micro Computer posted healthy growth that...
A single mobile title is proving that AI hype can’t single-handedly replace human creativity. This billion-dollar bea...
A rare Super El Niño looms, threatening multi-year droughts that could push already-stressed farms to the brink. With...
A private equity buyer has acquired the publishing stake in two Taylor Swift co-written hits, signaling a new frontie...
A high-stakes NBA scenario puts investor attention on payroll, sponsorships, and market bets. The potential LeBron mo...
With a midnight deadline looming, Trump says won’t sign the bipartisan housing package, risking automatic enactment. ...